Sucharita Roy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sucharita Roy

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Journal of Biomolecular Screening|April 9, 2015

A Quantitative Microtiter Assay for Sialylated Glycoform Analyses Using Lectin ComplexesKarunya Srinivasan, Sucharita Roy, Nathaniel Washburn, et al.

Applied Biochemistry and Biotechnology|May 12, 2023

Efficacy of High-Altitude Biofilm-Forming Novel Bacillus subtilis Species as Plant Growth-Promoting Rhizobacteria on Zea mays LBedaprana Roy, Debapriya Maitra, Abhik Biswas, et al.

Journal of Medicinal Chemistry|May 3, 2014

Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studiesSucharita Roy, Ahmed El Hadri, Sebastien Richard, et al.

Plos One|June 24, 2011

M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasisHe Zhou, Sucharita Roy, Edward Cochran, et al.

Mabs|February 12, 2025

Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular propertiesNilufer P Seth, Rui Xu, Matthew DuPrie, et al.

The New England Journal of Medicine|April 25, 2008

Contaminated heparin associated with adverse clinical events and activation of the contact systemTakashi Kei Kishimoto, Karthik Viswanathan, Tanmoy Ganguly, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Journal of Biomolecular Screening|April 9, 2015

A Quantitative Microtiter Assay for Sialylated Glycoform Analyses Using Lectin ComplexesKarunya Srinivasan, Sucharita Roy, Nathaniel Washburn, et al.

Applied Biochemistry and Biotechnology|May 12, 2023

Efficacy of High-Altitude Biofilm-Forming Novel Bacillus subtilis Species as Plant Growth-Promoting Rhizobacteria on Zea mays LBedaprana Roy, Debapriya Maitra, Abhik Biswas, et al.

Journal of Medicinal Chemistry|May 3, 2014

Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studiesSucharita Roy, Ahmed El Hadri, Sebastien Richard, et al.

Plos One|June 24, 2011

M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasisHe Zhou, Sucharita Roy, Edward Cochran, et al.

Mabs|February 12, 2025

Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular propertiesNilufer P Seth, Rui Xu, Matthew DuPrie, et al.

The New England Journal of Medicine|April 25, 2008

Contaminated heparin associated with adverse clinical events and activation of the contact systemTakashi Kei Kishimoto, Karthik Viswanathan, Tanmoy Ganguly, et al.

Pageof 2